Table 8. CMM financial characteristics of participating clinics (n=40).

Characteristic	N (%)
Payer mix of clinic overall by percentage*
Medicare, mean ± SD	23.2% ± 18.2
Medicaid, mean ± SD	25.5% ± 19.5
Dual eligible, mean ± SD	7.65% ± 13.7
Commercial (i.e., third party payer), mean ± SD	37.6% ± 23
Uninsured/Self-pay, mean ± SD	4.1% ± 6.7
Other, mean ± SD	2% ± 5.9
Payer mix of patients receiving CMM by percentage*
Medicare, mean ± SD	40.7% ± 30.0
Medicaid, mean ± SD	18.9% ± 22.8
Dual eligible, mean ± SD	8.4% ± 14.6
Commercial (i.e., third party payer), mean ± SD	27.4% ± 26.0
Uninsured/Self-pay, mean ± SD	2.9% ± 7.4
Other, mean ± SD	1.7% ± 5.3
Source of funding for providing CMM
Primary care medical practice	5 (12.5%)
The health care organization (e.g., health system, clinically integrated network)	27 (67.5%)
School or College of Pharmacy	9 (22.5%)
Partnering entity	1 (2.5%)
Other	3 (7.5%)
Billing third party payers for pharmacist services for pharmacist-provided patient care services	34 (85%)
Percent of CMM patients for whom pharmacists receive payment (n=32), mean ± SD	33.83% ± 33.28
Requirement that pharmacists have specific credentials or training beyond their pharmacy degree by payers to whom pharmacists submit claims to provide payment (n = 32)	8 (25%)

^*Combination of actual and respondent-estimated data